Noah C. Federman, MD

Noah Federman, MD

Health Sciences Clinical Associate Professor, Departments of Pediatrics and Orthopaedics
Medical Director, UCLA-CTSI Clinical and Translational Research Center
Chair, UCLA-CTSI Data Safety Monitoring Board
Vice Chair, UCLA-CTSI Scientific Rationale Council
Director, UCLA Pediatric Bone and Soft Tissue Sarcoma Program


English, Spanish


Pediatric Hematology/Oncology

Institutional Affiliation

UCLA Mattel Children's Hospital
Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica



Pediatric Hematology-Oncology, UCLA School of Medicine, 2005 - 2008


Pediatrics, UCLA School of Medicine, 2002 - 2003


MD, Mount Sinai School of Medicine, 2002


Pediatrics, UCLA School of Medicine, 2003 - 2005

Board Certifications

Pediatrics, American Board of Pediatrics, 2005
Pediatric Hematology/Oncology, American Board of Pediatrics, 2009

Contact Information

Clinical Interests

Children With Bone and Soft Tissue Sarcomas

Scientific Interests

Dr. Noah Federman specializes in treating children, adolescents and young adults who have the aggressive cancers of bone and soft tissue sarcomas. He helps oversee a state-of-the-art comprehensive and multidisciplinary program involving pediatric and medical oncologists, radiation oncologists, orthopedic oncology surgeons, musculoskeletal radiologists and pathologists, nuclear medicine specialists, physical therapists and prosthetic specialists. Federman's leads an experienced clinical research team devoted to providing access to clinical trials for children with refractory, recurrent and metastatic bone and soft tissue cancers. In addition, Federman is the Medical Director of the Clinical Translational Research Center, a part of the Clinical Translational Science Institute at UCLA, where he oversees the conduct of more than 200 human subject clinical trials at UCLA. In 2016 Federman was awarded the Sherman Mellinkoff Award, the highest faculty award in the David Geffen School of Medicine exemplifying the finest in teaching, doctor-patient relationships and the art of the practice of medicine.

Highlighted Publications

Nowicki TS, Anderson JL, Federman N. Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines. Pediatr Res. 2016 Mar;79(3):371-7. doi: 10.1038/pr.2015.246. Epub 2015 Nov 23.

Van Dyne E, Bernthal N, Federman N. Chapter 25 - Malignant Bone Tumors. Manual of Pediatric Hematology/Oncology. Lanzkowsky- Sixth Edition. Editors: Lanzkowsky P, Lipton JM, Fish JD. Elsevier, London UK. p 524-43. June 2016. ISBN: 978-0-12-801368-7.

Anderson JL, Park A, Akiyama R, Tap WD, Denny CT, Federman N. Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas. PLoS One. 2015 Sep 24;10(9):e0133610. doi: 10.1371/journal.pone.0133610. eCollection 2015.

Anderson JL, Denny CT, Tap WD, Federman N. Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities. Pediatr Res. 2012 Aug;72(2):112-21. Review.

Mitton B, Federman N. Alveolar soft part sarcomas: molecular pathogenesis and implications for novel targeted therapies. Sarcoma. 2012;2012:428789. doi: 10.1155/2012/428789. Epub 2012 Apr 8.